Doris J. Adamson
Southern Research Institute
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Doris J. Adamson.
Nucleosides, Nucleotides & Nucleic Acids | 1985
L. Lee Bennett; Chi-Hsiung Chang; Paula W. Allan; Doris J. Adamson; Lucy M. Rose; R. W. Brockman; John A. Secrist; Anita T. Shortnacy; John A. Montgomery
Abstract Within a series of halo derivatives of adenosine, deoxyadenosine and arabinosyladenine attempts have been made to correlate structure with cytotoxicity, substrate activity for adenosine deaminase and nucleoside kinases, and efficacy of the corresponding nucleotides against target enzymes.
Biochemical Pharmacology | 1984
Bonnie J. Bowdon; Glynn P. Wheeler; Doris J. Adamson; Y. Fulmer Sheal
Data for the alkylating activities, DNA cross-linking activities, and proliferation-inhibitory activities toward cultured L1210 cells for twenty-four 2-haloethyl sulfonates are reported. Previously reported activities against P388 leukemia in vivo are also presented to permit correlation of in vitro and in vivo properties. Since these compounds are believed to be 2-haloethylating agents, their properties and effects were compared with those of chlorozotocin, which is a recognized 2-chloroethylating agent. 2-Chloroethyl chloromethanesulfonate, which was the most effective compound against P388 leukemia, had a moderate level of alkylating activity and a low level of cross-linking activity, but it was quite active in inhibiting proliferation of cultured L1210 cells. Although its alkylating activity was about the same as that of chlorozotocin, it caused much less cross-linking of DNA. The in vitro tests were useful for gaining information relating structure to the individual properties, but results obtained for one of the properties might not be predictive of the relative values obtained for other properties nor for in vivo activity against P388 leukemia. These results indicate that additional experiments to define the mechanism of action of these agents are needed.
Cancer Research | 1975
J. Arly Nelson; Jean W. Carpenter; Lucy M. Rose; Doris J. Adamson
Cancer Research | 1972
Glynn P. Wheeler; Bonnie J. Bowdon; Doris J. Adamson; Margaret H. Vail
Cancer Research | 1979
L. Lee Bennett; Donald Smithers; Lucy M. Rose; Doris J. Adamson; H. Jeanette Thomas
Cancer Research | 1970
Glynn P. Wheeler; Bonnie J. Bowdon; Doris J. Adamson; Margaret H. Vail
Biochemical Pharmacology | 1970
L. Lee Bennett; Doris J. Adamson
Cancer Research | 1970
Glynn P. Wheeler; Bonnie J. Bowdon; Doris J. Adamson; Margaret H. Vail
Cancer Research | 1983
Glynn P. Wheeler; Bonnie J. Bowdon; Caroll Temple; Doris J. Adamson; Joliet Webster
Biochemical Pharmacology | 1984
L. Lee Bennett; Donald Smithers; Lucy M. Rose; Doris J. Adamson; R. W. Brockman